Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-09

Clinical Trial Update: Cyclophosphamide and Azathioprine vs Tacrolimus in Antisynthetase Syndrome-related Interstitial Lung Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing cyclophosphamide plus azathioprine versus tacrolimus in antisynthetase syndrome-related interstitial lung disease is underway, with un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azathioprine (azathioprine)
  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • Tacrolimus (Tacrolimus)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Antisynthetase Syndrome (ASS), Interstitial Lung Disease | Phase 3 | Status: UNKNOWN